DHRDanaher Corporation

$139B

Q4 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$8.1B+20.5% YoY

Gross Profit

$4.9B60.7% margin

Operating Income

$2.2B26.4% margin

Net Income

$1.8B21.9% margin

EPS (Diluted)

$2.39

QoQ Revenue Growth

+12.7%

Cash Flow

Operating Cash Flow

$2.3B

Free Cash Flow

$1.9B

Stock-Based Comp.

$59M

Balance Sheet

Total Assets

$83.2B

Total Liabilities

$38.0B

Stockholders' Equity

$45.2B

Cash & Equivalents

$2.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.1B	$6.8B	+20.5%
Gross Profit	$4.9B	$4.0B	+25.0%
Operating Income	$2.2B	$1.6B	+34.5%
Net Income	$1.8B	$1.2B	+44.1%

Revenue Segments

Revenue from Contract with Customer, Measurement, Recurring

$6.0B73%

Revenue from Contract with Customer, Measurement, Nonrecurring

$2.2B27%

DHR Q4 2021 Earnings — Danaher Corporation Revenue & Financial Results | Market Cap Arena